Posts detected
17
0.6 per day on average
Live account profile
@adamfeuerstein
Tier: Very Fast
@adamfeuerstein is a widely followed public account. Traders typically monitor this account for headline-driven sentiment changes that can create short-term trading opportunities. In the last 30 days, its content clustered around general updates.
Last 30 days: 17 detected posts, median alert timing 323ms, and latest detected post at Feb 27, 2026, 9:57 PM UTC. This is about 73ms slower than our ~250ms baseline.
Source profile: https://x.com/adamfeuerstein
17
0.6 per day on average
3
posts in last 24h (17 in last 7d)
323ms
p95: 771ms
148
avg chars per detected post
These values show how quickly alerts typically fire after a post appears. Use them to judge whether this account fits fast-reaction or slower confirmation strategies.
139ms
323ms
360ms
771ms
771ms
Peak windows: 21:00-22:00 UTC, 18:00-19:00 UTC, 14:00-15:00 UTC.
Active on 3 distinct days in the current 30-day window.
Data freshness date: 2026-02-28. Terms are recalculated from the most recent 30-day window.
These snippets come from recent detected posts for this handle. Each row includes post time, alert time, and measured delay.
$ASND approved
$ASND halted ahead of FDA decision on Transcon CNP for kids w/ achondroplasia.
$AARD Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome
(Hopefully) Final word today on the Makary $QURE (or was it $RGNX) thing: Bottom line: Makary shouldn't be talking publicly about unresolved drug applications. Uniqure doesn't even have an application submitted; and RegenxBio's CRL letter isn't posted to the F
@Rick_in_Miami The original study had a sham control
FDA Commissioner Marty Makary defends rare disease drug rejections, Vinay Prasad "Vinay Prasad is a genius,” Makary said. “He’s on loan from UCSF. He’s published over 500 scientific peer-reviewed articles, and some of the drugs they are criticizing him for tha
$RGNX therapy is delivered intrathecally into the spine, not via a burr hole in the head like $QURE
$QURE down this morning on comments made by FDA Commissioner Marty Makary to CNBC's Becky Quick. In a discussion about rare-disease drug approvals and Vinay Prasad, Makary said this: "I think there has been a bit of an effort to find a boogeyman to account for
@adamfeuerstein is a widely followed public account. Traders typically monitor this account for headline-driven sentiment changes that can create short-term trading opportunities. In the last 30 days, its content clustered around general updates.
This section is written for traders: who this account represents and why its posts can matter for markets.
Stats come from the rolling 30-day window and update as new posts are detected. Current freshness date: 2026-02-28.
Yes. ProfileTracer supports HTTP webhooks plus native formatting for Slack and Discord destinations.
Informational use only. ProfileTracer does not provide investment advice. Timing and content can vary based on upstream platform behavior, account activity, and destination delivery conditions.